Alpha2-Adrenergic Receptor-Induced Vascular Constriction in Blacks and Whites

Hypertension

Volumn 43, Issue 1, 2004, Pages 31-35

  Muszkat, Mordechai ^a   Sofowora, Gbenga G ^a   Wood, Alastair J J ^a   Stein, C Michael ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenergic receptor agonists; Ethnicity; Human; Receptors, adrenergic, alpha; Vasoconstriction; Veins

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; CLONIDINE; DEXMEDETOMIDINE;

ADULT; ARTICLE; CAUCASIAN; DOSE RESPONSE; DRUG RESPONSE; DRUG SENSITIVITY; ETHNIC DIFFERENCE; ETHNOLOGY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NEGRO; NORMAL HUMAN; PRIORITY JOURNAL; VENOCONSTRICTION;

EID: 0346788520     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000103694.30164.C7     Document Type: Article

References (26)

1. Saunders E. Hypertension in minorities: blacks. Am J Hypertens. 1995;8:115s-119s.
2. Kaplan NM. Ethnic aspects of hypertension. Lancet. 1994;344:450-452.
3. Falkner B, Kushner H. Race differences in stress-induced reactivity in young adults. Health Psychol. 1989;8:613-627.
4. Voors AW, Webber LS, Berenson GS. Racial contrasts in cardiovascular response tests for children from a total community. Hypertension. 1980;2:686-694.
5. Stein CM, Lang CC, Singh I, He HB, Wood AJ. Increased vascular adrenergic vasoconstriction and decreased vasodilation in blacks: additive mechanisms leading to enhanced vascular reactivity. Hypertension. 2000;36:945-951.
6. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo: the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med. 1993;328:914-921.
7. Cubeddu LX, Aranda J, Singh B, Klein M, Brachfeld J, Freis E, Roman J, Eades T. A comparison of verapamil and propranolol for the initial treatment of hypertension: racial differences in response. JAMA. 1986;256:2214-2221.
8. Calhoun DA, Mutinga ML, Wyss JM, Oparil S. Muscle sympathetic nervous system activity in black and Caucasian hypertensive subjects. J Hypertens. 1994;12:1291-1296.
9. Calhoun DA, Mutinga ML. Race, family history of hypertension, and sympathetic response to cold pressor testing. Blood Press. 1997;6:209-213.
10. Lang CC, Stein CM, He HB, Belas FJ, Blair IA, Wood M, Wood AJ. Blunted blood pressure response to central sympathoinhibition in normotensive blacks: increased importance of nonsympathetic factors in blood pressure maintenance in blacks. Hypertension. 1997;30:157-162.
11. Watkins LL, Dimsdale JE, Ziegler MG. Reduced beta 2-receptor mediated vasodilation in African Americans. Life Sci. 1995;57:1411-1416.
12. Cardillo C, Kilcoyne CM, Cannon RO III, Panza JA. Attenuation of cyclic nucleotide-mediated smooth muscle relaxation in blacks as a cause of racial differences in vasodilator function. Circulation. 1999;99:90-95.
13. Lang CC, Stein CM, Brown RM, Deegan R, Nelson R, He HB, Wood M, Wood AJ. Attenuation of isoproterenol-mediated vasodilatation in blacks. N Engl J Med. 1995;333:155-160.
14. Stein CM, Lang CC, Nelson R, Brown M, Wood AJ. Vasodilation in black Americans: attenuated nitric oxide-mediated responses. Clin Pharmacol Ther. 1997;62:436-443.
15. Haefeli WE, Srivastava N, Kongpatanakul S, Blaschke TF, Hoffman BB. Lack of role of endothelium-derived relaxing factor in effects of alpha-adrenergic agonists in cutaneous veins in humans. Am J Physiol. 1993;264:H364-H369.
16. Blochl-Daum B, Korn A, Wolzt M, Schmidt E, Eichler HG. In vivo studies on alpha-adrenergic receptor subtypes in human veins. Naunyn Schmiedebergs Arch Pharmacol. 1991;344:302-307.
17. Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol. 1988;150:9-14.
18. Aellig WH. Clinical pharmacology, physiology and pathophysiology of superficial veins. 2. Br J Clin Pharmacol. 1994;38:289-305.
19. Khan ZP, Ferguson CN, Jones RM. alpha-2 and imidazoline receptor agonists: their pharmacology and therapeutic role. Anaesthesia. 1999;54:146-165.
20. Aellig WH. Clinical pharmacology, physiology and pathophysiology of superficial veins. I. Br J Clin Pharmacol. 1994;38:181-196.
21. Callow ID, Campisi P, Lambert ML, Feng Q, Arnold JM. Enhanced in vivo alpha1- and alpha2-adrenoceptor-mediated venoconstriction with indomethacin in humans. Am J Physiol. 1998;275:H837-H843.
22. Schafers RF, Nurnberger J, Rutz A, Siffert W, Wenzel RR, Mitchell A, Philipp T, Michel MC. Haemodynamic characterization of young normotensive men carrying the 825T-allele of the G-protein beta3 subunit. Pharmacogenetics. 2001;11:461-470.
23. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans. II: hemodynamic changes. Anesthesiology. 1992;77:1134-1142.
24. Bentley GA, Widdop RE. Postjunctional alpha 2-adrenoceptors mediate venoconstriction in the hindquarters circulation of anaesthetized cats. Br J Pharmacol. 1987;92:121-128.
25. Muldowney SM, Faber JE. Preservation of venular but not arteriolar smooth muscle alpha-adrenoceptor sensitivity during reduced blood flow. Cilr Res. 1991;69:1215-1225.
26. Dinenno FA, Eisenach JH, Dietz NM, Joyner MJ. Post-junctional alpha-adrenoceptors and basal limb vascular tone in healthy men. J Physiol. 2002;540:1103-1110.